COVID-19: Vaccine Information for Providers

Recent News




Date/Time: Tuesday, March 2, at 2 p.m.
Featured Topic: What Clinicians Need to Know About the Janssen COVID-19 Vaccine (CDC)
Registration: Register through CDC
Date/Time: Friday, March 5, at 1 p.m.
Featured Topic: Updates on COVID-19 Vaccines
Registration: Register through WebEx


More Information on Vaccines

See guidance below for providers about COVID-19, including how you can get vaccinated.

Find a Vaccination Site and Vaccine Eligibility

Health care workers, other essential workers and several other groups of people are currently eligible to receive a vaccine.

  • COVID-19 Vaccine Finder: If you are eligible to receive a vaccine, find a location and learn how to schedule an appointment (not accessible with Internet Explorer).
  • You can also schedule an appointment by calling 877-VAX-4NYC (877-829-4692).
  • New York State COVID-19 Vaccine Form: Form required to complete before you get vaccinated.

Register to Provide Vaccinations

Become a Vaccine Provider

NYC providers who want to participate in the city's COVID-19 vaccine program will need to enroll with the Citywide Immunization Registry (CIR). They must use the CIR to electronically sign a provider agreement, place their order and report all doses administered.

Order Vaccine Doses

Once your Provider Agreement is approved by the NYC Health Department (and if you have appropriate vaccine storage), you will receive instructions on how to order vaccine doses through the CIR.

You will be notified when supply increases and doses have been allocated to you. Vaccine will be shipped directly to your facility from the manufacturer or the CDC’s distribution center.

Due to the limited supply of vaccine, the specific vaccine available will be determined by manufacturer supply, vaccination site and vaccine allocation.


You must offer the COVID-19 vaccine to all eligible people, regardless of insurance status or ability to pay.

You may not bill for the cost of the vaccine, but you are permitted to bill the recipient’s health insurance plan for an administration fee. If a recipient does not have health insurance, or if their insurance does not cover the administration fee, you can request reimbursement for the administration of the COVID-19 vaccine through the Federal Provider Relief Fund.

Vaccine Administration and Storage

Fact Sheets for Vaccine Providers

Fact Sheets for Recipients

You are required to communicate information consistent with these fact sheets to patients (and provide a copy or direct the patient to the fact sheet at the manufacturer's website) before they receive the respective vaccines.

Other Patient Handouts

Pre-Vaccination Screening

Vaccine Storage and Handling

Administration Standing Orders

How to Administer

Post-Injection Observation

You should observe the following groups of people for 30 minutes after vaccinating:

  • People with a history of an immediate allergic reaction of any severity to a vaccine or injectable therapy
  • People with a history of anaphylaxis due to any cause

Observe all other people for 15 minutes after injection.


You must report each vaccine administration to both of the systems listed below. Patient consent is not required.

For information on reporting an adverse event in VAERS, see the Adverse Events Reporting section.

Vaccine Communication and Encouragement

Your recommendation is one of the strongest predictors that a patient will get vaccinated. Consider using these resources to help build vaccine confidence among staff and patients.

Presentations and Materials for Health Care Staff

Online Resources for Patients

Direct your patients to the COVID-19: Vaccine Eligibility page so they can stay up to date on who is eligible for the vaccine. Begin talking with them now about the benefits and risks of the COVID-19 vaccine.

Underlying Conditions

Vaccine Benefits


Handouts for Patients


General FAQs and Resources

After Vaccination


  • Webinar Slides: COVID-19 Vaccine Updates for Independent Pharmacies (PDF, February 24). COVID-19 vaccination in the retail pharmacy setting, including information on enrollment, ordering vaccine, moderna vaccine storage and handling, clinical considerations, reporting, and prioritization.
  • The New York State Department of Health released a Non Patient-Specific Standing Order for the Administration of the Moderna COVID-19 Vaccination in New York Retail Pharmacies. Pharmacies who need this standing order can email to get one.

Long-Term Care Facilities

Mental Hygiene Providers

Physical Space and Workflow

An effective COVID-19 vaccination program may require changes to your scheduling, waiting room and patient flow.

Waiting Room

  • Determine if there are other areas where patients can wait if waiting room capacity is limited.
  • Plan for accommodations in case of inclement weather, when waiting outdoors is not possible.

Monitoring for Side Effects

  • Review CDC guidance on preparing for anaphylaxis (CDC).
  • Determine where patients can be safely monitored while still maintaining social distance, such as an exam room or observation area.
  • If you monitor patients in the exam room, allow time in your schedule for observation and managing exam room use.

Temporary Locations

Clinical Considerations and Safety

Clinical Considerations

Post-Vaccination Symptoms

Safety Data

Adverse Events Reporting

Certain adverse events must be reported to the Vaccine Adverse Event Reporting System (VAERS).

Best Practices and Quality Improvement

Resources including best practices to maximize efficacy and efficiency of your program.

  • FQHC COVID-19 Vaccination Best Practices (PDF, February 9): Suggestions for planning, implementation and promotion.
  • Hospital COVID-19 Vaccination Best Practices (PDF, January 7): Best practices in planning and coordination, vaccine administration, vaccine distribution, prioritization and eligibility, clinic screening and safety, and patient/staff communication.
  • Model for Improvement Framework (Institute for Healthcare Improvement): Resources for process improvement work, such as setting goals, establishing measures, and testing changes (Plan-Do-Study-Act or PDSA cycles).

Vaccine Authorization Process

The below resources outline the process for COVID-19 vaccine development, from research to clinical trials to Emergency Use Authorization (EUA).

FDA Reviews

Advisory Committee on COVID-19 (ACIP)

Journal Articles

Data on Vaccine Distribution

We encourage you to collect and report COVID-19 vaccine recipients’ race and ethnicity data to help us monitor inequities and address barriers to vaccine access and distribution. For details, see the Reporting header in the Storage and Administration section.

The following resources show data on vaccine allocation, distribution and administration.

Trainings and Webinars


Training Modules on COVID-19 Vaccines


Past webinar videos and slides are provided here for reference. They may not contain the most up-to-date information.



Additional Resources